Valuation: SpineGuard

Market Cap 8.04M 9.28M 7.51M 6.87M 12.94M 885M 13.14M 88.09M 34.57M 443M 34.86M 34.1M 1.48B P/E 2024
-3.63x
P/E 2025 -3.37x
Enterprise Value 7.77M 8.98M 7.26M 6.64M 12.51M 856M 12.71M 85.18M 33.43M 428M 33.71M 32.97M 1.43B EV / Sales 2024
2.94x
EV / Sales 2025 2.33x
Free-Float
97.68%
Yield 2024 *
-
Yield 2025 -
1 day+3.15%
1 week+3.52%
Current month+6.13%
1 month+6.39%
3 months-13.09%
6 months-28.79%
Current year-12.57%
1 week 0.08
Extreme 0.085
0.1
1 month 0.08
Extreme 0.0802
0.1
Current year 0.08
Extreme 0.075
0.14
1 year 0.08
Extreme 0.075
0.3
3 years 0.08
Extreme 0.075
0.5
5 years 0.08
Extreme 0.075
1.77
10 years 0.08
Extreme 0.075
5.49
Manager TitleAgeSince
Chief Executive Officer - 15/02/2020
Director of Finance/CFO - 01/01/2009
Chief Tech/Sci/R&D Officer - 01/09/2019
Director TitleAgeSince
Director/Board Member - 16/01/2009
Director/Board Member - 02/07/2009
Chairman - 01/03/2018
Change 5-day change 1-year change 3-year change Capi.($)
+3.15%+3.52%-10.45%-79.79% 9.28M
+0.14%+0.65%+36.25%+31.88% 12.84B
+0.06%-0.13%+20.56%+27.16% 6.87B
+5.64%+9.50%+59.16%+38.76% 6.51B
-0.18%+3.16% - - 5.48B
+3.20%-1.39%-24.46%+44.12% 4.41B
+0.77%-2.17%-21.87%-17.42% 4.08B
+0.52%+7.01%+59.72%-44.27% 2.02B
-8.28%-10.59%-24.00%+124.95% 1.73B
+0.92%+6.50%+68.55%-10.15% 1.71B
Average +0.60%+753.27%+18.16%+12.80% 4.56B
Weighted average by Cap. +0.96%+778.47%+24.66%+26.91%

Financials

2024 2025
Net sales 4.65M 5.37M 4.34M 3.97M 7.48M 512M 7.6M 50.95M 19.99M 256M 20.16M 19.72M 853M 3.76M 4.34M 3.51M 3.21M 6.05M 414M 6.14M 41.18M 16.16M 207M 16.3M 15.94M 690M
Net income -3.08M -3.56M -2.88M -2.63M -4.96M -340M -5.04M -33.78M -13.25M -170M -13.37M -13.08M -566M -2.07M -2.39M -1.93M -1.77M -3.33M -228M -3.38M -22.66M -8.89M -114M -8.97M -8.77M -380M
Net Debt 1.82M 2.1M 1.7M 1.55M 2.93M 200M 2.97M 19.93M 7.82M 100M 7.89M 7.72M 334M -265K -307K -248K -227K -427K -29.24M -434K -2.91M -1.14M -14.63M -1.15M -1.13M -48.71M
Logo SpineGuard
SpineGuard specializes in the design, development, and marketing of medical devices intended to improve the safety of spinal surgery. The group is developing DSG® digital technology for real-time surgical guidance without X-rays to improve the safety and simplify the placement of bone implants, pedicle screws, and "smart" drills. SpineGuard is extending the applications of its DSG® technology to anterior scoliosis treatment, sacroiliac joint fusion, and dental implantology.
Employees
13
Date Price Change Volume
12/08/26 EUR 0.0883 +3.15% 114,288
10/08/26 EUR 0.0856 -1.04% 540,517
07/08/26 EUR 0.0865 -2.48% 188,201
06/08/26 EUR 0.0887 -4.52% 830,244
05/08/26 EUR 0.0929 +8.91% 551,304
  1. Stock Market
  2. Stocks
  3. ALSGD Stock